Search results
From being labeled as 'selfish' for taking out time for herself to sharing her love for Gujarati...
The Times of India· 3 days agoFrom being labeled as selfish for prioritizing self-care to sharing her passion for Gujarati...
ProJoint Plus Review: Best Joint Pain Supplement or Hoax?
Mid Day· 1 hour agoProJoint Plus Review is a supplement that has been developed in a way that helps to support joint health and possibly improve it. Do you have joint pain? Joint pain could result from an accident ...
What is causing IPO boom in India? Why are experts worried about investor frenzy? | Stock Market...
Livemint· 4 hours agoStock market today: The Indian capital market witnessed a healthy flow of initial public offerings...
Grier explains Sharks' full-circle Celebrini-Thornton moment
NBC Sports BayArea· 2 days agoNot only them both being [No. 1 overall] picks, but from the Sharks [perspective], what was a No. 1...
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 5 hours agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...
Ambey Laboratories IPO price band set at ₹65-68 per share; SME IPO to open on July 4 | Stock Market...
Livemint· 24 hours agoAmbey Laboratories IPO price band has been fixed at ₹65 - ₹68 per share. Ambey Laboratories IPO is...
Taarak Mehta Ka Ooltah Chashmah, CID, and others: 10 Indian shows that ran for the longest times on...
Pinkvilla· 3 days agoTV shows have been a staple for the Indian masses for ages. People across the nation somehow manage...
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 4 hours agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
boAt Co-founder Aman Gupta Turns 'Swiftie' After Attending Taylor Swift Concert With Daughter -...
News18· 6 days agoAman Gupta, co-founder of boAt and a judge of Shark Tank India has officially joined the group of...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 4 hours agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...